- 4.8Impact Factor
- 7.7CiteScore
- 16 daysTime to First Decision
Special Issues
Pharmaceuticals publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Peptide Synthesis and Drug Development: Exploring Progress and Potential, 2nd Edition
Deadline: 31 July 2026
Advanced Three-Dimensional In Vitro Models for Disease Biology and Pharmaceutical Development
Deadline: 31 July 2026
Treating Cognitive Deficits in Neuropsychiatric and Neurodegenerative Disorders: Mechanisms, Targets, and Translational Advances
Deadline: 31 July 2026
Advances in GPCR Drug Discovery
Deadline: 31 July 2026
Supersaturated Formulations in Drug Development: From Solubility Investigations to the Advancement of In Vitro–In Vivo Predictability
Deadline: 31 July 2026
New Advances and Treatment in Thrombosis and Endothelial Injury Syndromes
Deadline: 31 July 2026
Advances in Hybrid Anticancer Drugs: Innovations and Therapeutic Potential
Deadline: 25 July 2026
Research Progress and Drug Intervention Strategies for Oral Health-Related Diseases
Deadline: 25 July 2026
Clinical Advances in the Neuropharmacological Treatment of Substance Use Disorders: 2nd Edition
Deadline: 25 July 2026
Therapeutic Drug Monitoring and Adverse Drug Reactions: 3rd Edition
Deadline: 25 July 2026
Drug Target Exploration and Drug Design & Development Based on Small Molecule: 2nd Edition
Deadline: 25 July 2026
Development of Biomaterials for Targeted and Localized Cancer Drug Release
Deadline: 25 July 2026
of 81

